Annual Report 2025

CONSOLIDATED STATEMENT OF CASH FLOWS For the year ended 31 December 2025 53 The United Laboratories International Holdings Limited Annual Report 2025 2025 2024 RMB’000 RMB’000 Investing activities Payments for purchase of property, plant and equipment (2,726,679) (1,431,869) Payment for deposits of acquisition of property, plant and equipment (75,818) (283,298) Proceeds on disposal of property, plant and equipment 34,653 9,514 Placement of pledged bank deposits (2,769,028) (4,827,996) Withdrawal of pledged bank deposits 3,174,891 4,765,879 Placement of financial asset at fair value through profit and loss (47,223,881) (20,818,787) Receipts of financial asset at fair value through profit and loss 47,303,259 20,885,788 Receipts of government grants 56,523 – Interest received 152,573 127,791 Additions to right-of-use assets (7,911) (60,386) Additions to intangible assets (83,959) (94,727) Net cash used in investing activities (2,165,377) (1,728,091) Financing activities Interest paid (127,263) (68,398) Dividends paid (1,042,496) (1,017,535) Capital contribution from the non-controlling interest of a subsidiary 40,225 36,000 Repayments of lease liabilities (5,126) (5,266) New borrowings raised 4,037,487 2,227,570 Repayments of borrowings (2,205,129) (586,140) Net settlement of foreign currency forwards 133,658 47,254 Payment on purchase of shares for share award scheme (41,423) (36,465) Transaction costs attributable to purchase of shares for share award scheme (130) (112) Proceeds from issuance of shares 1,989,881 – Net cash from financing activities 2,779,684 596,908 Net increase in cash and cash equivalents 4,364,127 2,068,119 Effect of foreign exchange rate changes (87,578) (267) Total cash and cash equivalents at beginning of the year 6,329,841 4,261,989 Total cash and cash equivalents at end of the year 10,606,390 6,329,841